Skip to content

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform:
Publications

man working - Alto publications hero

Leveraging clinical and biological insights to drive innovation in psychiatry

See our publications, presentations, and more to discover the revolutionary potential of our precision approach.

Choose Resource Type
Choose Focus Area
Search Resources

Found 44 Results

July 13, 2022

Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia

December 1, 2021

A data-driven framework for mapping domains of human neurobiology

August 30, 2021

Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence

April 1, 2021

Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography

August 27, 2020

The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial

July 14, 2020

Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders

April 1, 2020

An electroencephalographic signature predicts antidepressant response in major depression

«1 234 5...»

650 Castro Street, Suite 450
Mountain View, CA 94041

Company

About
Leadership
Careers
Contact

Science

Platform
Publications
Pipeline

Investors

Overview
News
Events & Presentations
Stock Info
SEC Filings
Corporate Governance
Resources

Privacy Policy
Terms of Use
Accessibility
Cookie Policy

© 2024 Alto Neuroscience Inc. All rights reserved.

Scroll to Top